QLYS.NASDAQQualys, INC

Form 4: Qualys CEO Sumedh Thakar Executes Stock Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Qualys CEO Sumedh Thakar exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On March 14, 2025, Sumedh S. Thakar, CEO and President of Qualys, Inc., executed a stock option to acquire 7,000 shares of common stock at a price of $25.56 per share.
  • Simultaneously, Thakar sold 7,000 shares of Qualys common stock in a series of transactions at weighted average prices ranging from $123.4928 to $126.2416 per share.
  • These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on February 28, 2024.
  • Following these transactions, Thakar directly owns 246,313 shares of Qualys common stock and 59,000 derivative securities (stock options).

Sentiment

Score: 6

Explanation: Neutral sentiment as the filing simply reports transactions under a pre-existing plan. No indication of positive or negative outlook.

Positives

  • The transactions were conducted under a pre-arranged 10b5-1 trading plan, which is generally viewed as a transparent and compliant way for insiders to sell shares.

Risks

  • While the sales are under a 10b5-1 plan, large insider sales can sometimes be perceived negatively by the market.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Insider transactions are common and closely watched in the tech industry. Sales under 10b5-1 plans are a regular occurrence.

Comparison to Industry Standards

  • Comparing Thakar's transactions to other tech CEOs, the volume of shares sold is within a typical range for executives exercising options and diversifying their holdings.
  • Similar to executives at companies like CrowdStrike and Okta, Thakar's use of a 10b5-1 plan aligns with standard practices for managing insider trading risks.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the potential dilution from option exercises and the selling pressure from the stock sales, although the 10b5-1 plan mitigates concerns about opportunistic trading.

Key Dates

DateDescription
February 28, 2024Date the Reporting Person adopted the Rule 10b5-1 trading plan
March 14, 2025Date of the stock option exercise and stock sales
April 28, 2026Expiration date of the stock option
March 18, 2025Date of the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.